CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close

Science and Research

ADVISE: Adalimumab vs. Conventional Immunosuppression for Corticosteroid-sparing for Uveitis Trial

The ADVISE Trial is a randomised, parallel-treatment, comparative effectiveness trial. 

Overview

The ADVISE Trial is a randomised, parallel-treatment, comparative effectiveness trial.

It aims to compare the relative effectiveness of adalimumab compared to conventional immunosuppression at controlling ocular inflammation caused by uveitis, while permitting tapering and discontinuation of oral corticosteroids.

  • Principal Investigator
Professor Lyndell Lim

Learn more

View this study at ClinicalTrials.gov

This international database listing provides more detailed information about this study.

Read More

Related Pages

Clinical trials

Refer a patient

We welcome referrals from healthcare practitioners of patients who may be suitable for a clinical trial at CERA.

Clinical trials

Register your interest in clinical trials

To express interest in taking part in current or future clinical trials at CERA, please join our online database below. First, here are some important things you need to know.